The purpose of this study is to evaluate the effects of 30 mL intraperitoneal Bupivacaine without epinephrine 0.25% on postoperative pain control in patients undergoing pelvic organ prolapse repair. The investigators hypothesize that use of intraperitoneal Bupivacaine will decrease postoperative pain scores and opiate consumption in the postoperative period, following pelvic organ prolapse repair.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
91
Intraperitoneal Bupivicaine without epinephrine 30 mg administered following completion of pelvic organ prolapse repair.
Placebo
IU north
Carmel, Indiana, United States
Pain Score at 4 Hours
Patient pain will be measured by means of a numeric rating scale (scale from 0-10 with lower numbers indicating less pain and higher numbers indicating more pain) at 4 hours after surgical pelvic organ prolapse repair
Time frame: 4 hours
Pain Score at 8 Hours, 12 Hours and 24 Hours
Pain scores as determined by numeric rating scale (scale from 0-10 with lower numbers indicating less pain and higher numbers indicating more pain) at approximately 8, 12 and 24 hours
Time frame: 8 hours, 12 hours and 24 hours
Total Opiate Consumption
Total opiate consumption postoperatively while inpatient as determined by morphine milligram equivalents (MME)
Time frame: First 24 hours postoperatively
Time to First Narcotic
Time to first narcotic dose during inpatient stay
Time frame: Up to 24 hours
Hospital Length of Stay
Hospital length of stay
Time frame: Up to 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.